http://www.law360.com/ Latest articles for organization: Pfizer Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/135646 A Pennsylvania jury has ruled that two Pfizer Inc. units are on the hook for at least $6.3 million in compensatory damages to an Illinois woman who developed breast cancer after she began taking popular menopause drugs Prempro and Provera. http://www.law360.com/articles/135646 http://www.law360.com/articles/134847 Recent statements by U.S. Food and Drug Administration and Department of Justice officials, including FDA Commissioner Margaret Hamburg, promised an increase in enforcement. And events on several fronts, including a recent criminal indictment against Stryker Biotech and four current or past executives, demonstrate that this is no idle threat, say Erin Reilly Lewis and Ralph F. Hall of Baker & Daniels LLP. http://www.law360.com/articles/134847 http://www.law360.com/articles/135185 The head of the European Commission's pharmaceutical task force reportedly told drug companies Thursday of plans to ask for details on patent deals with generic-drug makers that are suspected of delaying the entry of cheaper drugs into the market. http://www.law360.com/articles/135185 http://www.law360.com/articles/134979 The federal government has asked a judge to approve a nearly $6 million settlement between it and several defendants, including Exxon Mobil Corp., in a long-running dispute over contamination from a former Monsanto Co. plant in southern Illinois. http://www.law360.com/articles/134979 http://www.law360.com/articles/133859 Accused of contributing to deadly contamination in Sauget, Ill., Pfizer Inc. is contending it has no viable connection to the town's Monsanto chemical plant — long the nation’s largest producer of polychlorinated byphenyls. http://www.law360.com/articles/133859 http://www.law360.com/articles/132933 Plaintiffs have dropped their putative class action accusing Pfizer Inc. of fraudulently marketing Lipitor by covering up certain side effects and misrepresenting the cholesterol drug's efficacy in some patient groups. http://www.law360.com/articles/132933 http://www.law360.com/articles/132433 While the verdict officially remains under wraps, word is spreading that a Pennsylvania jury has ordered Pfizer Inc. to fork over $75 million in punitive damages to a woman who developed invasive breast cancer after she began taking the popular menopause drug Prempro. http://www.law360.com/articles/132433 http://www.law360.com/articles/132248 The U.S. Department of Commerce is lauding the White House's recent pick of Suresh Kumar to the post of director general of the U.S. and Foreign Commercial Service. http://www.law360.com/articles/132248 http://www.law360.com/articles/131834 The U.S. Supreme Court has asked Solicitor General Elena Kagan to weigh in on the Alien Tort Statute in a case involving pharmaceutical giant Pfizer Inc.'s medical experiments in Nigeria. http://www.law360.com/articles/131834 http://www.law360.com/articles/131863 A federal appeals court has ruled that a judge rightly threw out a $27 million award to a woman who claimed Wyeth and a Pfizer Inc. subsidiary failed to warn about the cancer risk of their controversial hormone replacement treatment because of expert testimony the judge said should not have been allowed. http://www.law360.com/articles/131863 http://www.law360.com/articles/131501 Plaintiffs in a long-running dispute over pension plans for employees of agricultural giant Monsanto Corp. and two spinoff health care companies have appealed a district court decision tossing their class action claims that the pension plans improperly calculated their benefits in violation of federal law. http://www.law360.com/articles/131501 http://www.law360.com/articles/131483 Merck & Co.’s proposed $41.1 billion acquisition of Schering-Plough Corp. has gained approval from U.S. antitrust regulators on the condition that both companies shed certain assets. http://www.law360.com/articles/131483 http://www.law360.com/articles/131152 Pfizer Inc. is again trying to fend off a lawsuit by a group of California pharmacies and pharmacists claiming the drugmaker's $68 billion buyout of rival Wyeth will eliminate competition and stifle innovation in the U.S. prescription drug market. http://www.law360.com/articles/131152 http://www.law360.com/articles/131288 A magistrate judge in a contract and trade secrets suit brought by Brigham Young University and a professor who claims he had a key role in discovering an enzyme that led to the development of Bextra and Celebrex has sanctioned the drugs' maker, a move the judge said she hoped would entice Pfizer Inc. to comply with its discovery obligations. http://www.law360.com/articles/131288 http://www.law360.com/articles/131010 A British charitable trust has slapped Amgen Inc. and Pfizer Inc. subsidiary Wyeth with a lawsuit over the lucrative rheumatoid arthritis drug Enbrel, accusing the two defendants — which co-market Enbrel in the U.S. — of willfully infringing a single patent and ignoring demands for royalty payments. http://www.law360.com/articles/131010 http://www.law360.com/articles/130536 In a one-two punch to Pfizer Inc., a Philadelphia jury has reportedly awarded punitive damages in addition to $3.7 million in compensatory damages to a woman who developed invasive breast cancer after she began taking Prempro, which is made by the company’s Wyeth unit. http://www.law360.com/articles/130536 http://www.law360.com/articles/130011 EU antitrust regulators have cleared Merck & Co.’s proposed $41.1 billion acquisition of Schering-Plough Corp., a move that will make it the second-largest prescription drug company in the world. http://www.law360.com/articles/130011 http://www.law360.com/articles/123719 This article discusses various aspects of Chinese intellectual property policy and progress as a consequence of the World Trade Organization-driven and, more recently, innovation-driven history of Chinese IP law, say Dr. Qian Huang and Paul Devinsky of McDermott Will & Emery LLP. http://www.law360.com/articles/123719 http://www.law360.com/articles/123120 One of the most challenging problems in international trade law today is that many clients must operate in a manner that serves the seemingly inconsistent regulations of several countries, says Stanley U. North III, a partner in LeClairRyan's corporate group who specializes in international trade. http://www.law360.com/articles/123120 http://www.law360.com/articles/128930 A federal court has levied a record $1.3 billion criminal fine — the largest ever imposed in the U.S. — against Pfizer Inc. subsidiary Pharmacia & Upjohn Co. Inc. for fraudulently misbranding its anti-inflammatory drug Bextra. http://www.law360.com/articles/128930